Ascenta Fund I

About Ascenta Fund I

Biotech, Multi-Medicine Platforms, Therapeutics, AI-enabled Drug Discovery. Early Stage, Seed, Series A/B.

Investment Focus

Location / RegionUnited States

Funding StageSeed

Industry Focus

Ai Ml

Biotech

Therapeutics

Investor Signals Profile

active

Sweet Spot

Biotech founder translating preclinical science into Phase 1-2

biotech

phase 1-2 clinical

drug development

multi-medicine platforms

science-to-medicine

Bullish Signals

$335M AUM, biotech-focusedexternal

$15-30M concentrated check sizesexternal

Hands-on strategic + operational supportexternal

Biotech renaissance — active deployment nowexternal

Network: mgmt, scientists, clinical investigatorsexternal

Team: strategists, developers, operators, dealmakersexternal

Contrarian Signals

Very narrow biotech-only mandateexternal

Concentrated bets — fewer portfolio slotsexternal

Founder Do's

Have development candidates ready

Show clear patient unmet need

Bring translational science depth

Embrace collaborative operator model

Platform with multi-asset potential

Founder Don'ts

Pre-candidate / discovery-only stage

Non-biopharma sectors

Solo founder, no scientific team

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$325M

Saves0

Website

Key People

Evan Rachlin, Lorence Kim